The HLA-DR phenotype modulates the humoral immune response to enterovirus antigens

被引:43
作者
Sadeharju, K
Knip, M
Hiltunen, M
Åkerblom, HK
Hyöty, H
机构
[1] Univ Tampere, Dept Virol, Sch Med, FIN-33101 Tampere, Finland
[2] Tampere Univ Hosp, Dept Microbiol, Ctr Lab Med, Tampere, Finland
[3] Univ Helsinki, Hosp Children & Adolescents, Helsinki, Finland
[4] Tampere Univ Hosp, Dept Pediat, Tampere, Finland
[5] Acad Finland, Tampere, Finland
[6] JDRF Ctr Prevent Type 1 Diabet Finland, Tampere, Finland
基金
芬兰科学院;
关键词
HLA-DR; enterovirus; Type; 1; diabetes; mumps; immune response; vaccine;
D O I
10.1007/s00125-003-1157-x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims/hypothesis. Enterovirus infections are among the environmental risk factors potentially contributing to the pathogenesis of Type 1 diabetes. The aim of this study was to evaluate virus-host interaction by analysing the enterovirus antibody levels in subjects carrying different HLA-DR alleles associated with either increased or decreased risk of Type 1 diabetes. Methods. Antibodies against coxsackievirus B4 were measured to study immune responses induced by natural enterovirus infections and against poliovirus 1 to study immune responses induced by immunisation by enterovirus antigens (vaccine). Antibodies against the mumps virus were measured as a control. Study subjects included siblings of children with Type 1 diabetes taking part in the Childhood Diabetes in Finland (DiMe) Study and carrying either HLA-DR risk (DR3 and/or DR4) or protective (DR2) alleles. Results. Children with either the HLA-DR3 or HLA-DR4 allele and those with both these risk alleles had higher Coxsackie B4 antibody levels than children carrying the HLA-DR2 allele (p=0.01, p=0.01 and p=0.008, respectively). High responders (IgG levels higher than 75 percent) were also more frequent among genetically susceptible children compared to children with the protective DR2 allele (27% vs 12%) (p<0.009). The same trend was seen for poliovirus antibodies, while mumps antibody levels had a different pattern (high responders more common among DR2-positive subjects). Conclusions/interpretation. Diabetes-associated HLA-DR risk alleles were associated with a strong immune responsiveness and protective alleles with a weak responsiveness against enterovirus antigens. This phenomenon should be taken into consideration in serological case-control studies and it might play a role in virus-induced beta-cell damage.
引用
收藏
页码:1100 / 1105
页数:6
相关论文
共 24 条
[1]   HLA and in vitro susceptibility to HIV infection [J].
Al Jabri, AA .
MOLECULAR IMMUNOLOGY, 2002, 38 (12-13) :959-967
[2]  
Bertoletti A, 1996, Acta Biomed Ateneo Parmense, V67, P87
[3]   HLA-DR3 AND HLA-DR4 CONTROL LYMPHOCYTE-T RESPONSES TO MUMPS AND COXSACKIE-B4 VIRUS - STUDIES ON PATIENTS WITH TYPE-1 (INSULIN-DEPENDENT) DIABETES AND HEALTHY-SUBJECTS [J].
BRUSERUD, O ;
JERVELL, J ;
THORSBY, E .
DIABETOLOGIA, 1985, 28 (07) :420-426
[4]   HLA CONTROL OF THE PROLIFERATIVE LYMPHOCYTE-T RESPONSE TO ANTIGENIC DETERMINANTS ON MUMPS-VIRUS - STUDIES OF HEALTHY-INDIVIDUALS AND PATIENTS WITH TYPE-1 DIABETES [J].
BRUSERUD, O ;
THORSBY, E .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1985, 22 (05) :509-518
[5]   A CASE-CONTROL STUDY OF GROUP-B COXSACKIEVIRUS IMMUNOGLOBULIN-M ANTIBODY PREVALENCE AND HLA-DR ANTIGENS IN NEWLY DIAGNOSED CASES OF INSULIN-DEPENDENT DIABETES-MELLITUS [J].
DALESSIO, DJ .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1992, 135 (12) :1331-1338
[6]   Human leukocyte antigen class II alleles may contribute to the severity of hepatitis C virus-related liver disease [J].
Hüe, S ;
Cacoub, P ;
Renou, C ;
Halfon, P ;
Thibault, V ;
Charlotte, F ;
Picon, M ;
Rifflet, H ;
Piette, JC ;
Pol, S ;
Caillat-Zucman, S .
JOURNAL OF INFECTIOUS DISEASES, 2002, 186 (01) :106-109
[7]  
HYOTY H, 1985, CLIN EXP IMMUNOL, V60, P139
[8]   A PROSPECTIVE-STUDY OF THE ROLE OF COXSACKIE-B AND OTHER ENTEROVIRUS INFECTIONS IN THE PATHOGENESIS OF IDDM [J].
HYOTY, H ;
HILTUNEN, M ;
KNIP, M ;
LAAKKONEN, M ;
VAHASALO, P ;
KARJALAINEN, J ;
KOSKELA, P ;
ROIVAINEN, M ;
LEINIKKI, P ;
HOVI, T ;
AKERBLOM, HK ;
TUOMILEHTO, J ;
LOUNAMAA, R ;
TOIVANEN, L ;
VIRTALA, E ;
PITKANIEMI, J ;
FAGERLUND, A ;
FLITTNER, M ;
GUSTAFFSON, B ;
HAGGQVIST, C ;
HAKULINEN, A ;
HERVA, L ;
HILTUNEN, P ;
HUHTAMAKI, T ;
HUTTUNEN, NP ;
HUUPPONEN, T ;
HYTTINEN, M ;
JOKI, T ;
JOKISALO, R ;
KAAR, ML ;
KALLIO, S ;
KAPRIO, EA ;
KASKI, U ;
LAINE, L ;
LAPPALAINEN, J ;
MAENPAA, J ;
MAKELA, AL ;
NIEMI, K ;
NIIRANEN, A ;
NUUJA, A ;
OJAJARVI, P ;
OTONKOSKI, T ;
PIHLAJAMAKI, K ;
PONTYNEN, S ;
RAJANTIE, J ;
SANKALA, J ;
SCHUMACHER, J ;
SILLANPAA, M ;
STAHLBERG, MR ;
STRAHLMANN, CH .
DIABETES, 1995, 44 (06) :652-657
[9]   Enterovirus infections and type I diabetes [J].
Hyöty, HL .
ANNALS OF MEDICINE, 2002, 34 (03) :138-147
[10]   HLA-DW2 AS A MARKER OF RESISTANCE AGAINST JUVENILE DIABETES-MELLITUS [J].
ILONEN, J ;
HERVA, E ;
TIILIKAINEN, A ;
AKERBLOM, HK ;
KOIVUKANGAS, T ;
KOUVALAINEN, K .
TISSUE ANTIGENS, 1978, 11 (02) :144-146